推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Therapeutic Advances in Medical Oncology

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 THER ADV MED ON最新评论:administrative checks complete initial checks have been completed and editor assignment is being determined 这个状态维持... (2024-01-15)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


Therapeutic Advances in Medical Oncology期刊基本信息Hello,您是该期刊的第39076位访客

基本信息 登录收藏
期刊名字Therapeutic Advances in Medical OncologyTherapeutic Advances in Medical Oncology

THER ADV MED ONCOL
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.1
53人评分
我要评分

声誉
8.1

影响力
6.4

速度
6.9

期刊ISSN1758-8340
微信扫码收藏此期刊
E-ISSN1758-8359
2022-2023最新影响因子
(数据来源于搜索引擎)
4.9 点击查看影响因子趋势图
实时影响因子 截止2023年12月27日:3.752
2022-2023自引率2.00%点击查看自引率趋势图
五年影响因子5.6
h-index 34
CiteScore
CiteScoreSJRSNIPCiteScore排名
8.301.5141.220
学科分区排名百分位
大类:Medicine
小类:Oncology
Q172 / 366

期刊简介
Therapeutic Advances in Medical Oncology delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of cancer. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in medical oncology, providing an online forum for rapid dissemination of recent research and perspectives in this area.

The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.

Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). Therapeutic Advances in Medical Oncology conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

The journal adheres to a blind review process in which the reviewer’s name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees; and Online First publication is usually within 3 weeks of Acceptance.
期刊官方网站https://journals.sagepub.com/home/tam
期刊投稿网址https://mc.manuscriptcentral.com/tao
作者指南网址https://journals.sagepub.com/author-instructions/TAM
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Therapeutic Advances in Medical Oncology的语言要求,还能让Therapeutic Advances in Medical Oncology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Therapeutic Advances in Medical Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( USD2300; )
文章处理费豁免:查看说明

其他费用:没有
期刊主题关键词:oncology、cancer
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardBlind peer review
通讯方式SAGE PUBLICATIONS LTD, 1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP
出版商SAGE Publications Inc.
涉及的研究方向ONCOLOGY-
出版国家或地区ENGLAND
出版语言English
出版周期Continuous publication
出版年份2009
年文章数 170点击查看年文章数趋势图
Gold OA文章占比94.58%
研究类文章占比:
文章 ÷(文章 + 综述)
65.29%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:2区

按学科分区JIF分区JIF排名JIF百分位
学科:ONCOLOGY
类别:SCIE
Q278/241
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区2区3区
ONCOLOGY
肿瘤学
4区4区3区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区2区4区
ONCOLOGY
肿瘤学
2区3区3区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区2区1区
ONCOLOGY
肿瘤学
3区1区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1758-8340%5BISSN%5D
平均审稿速度网友分享经验:
15 Weeks
平均录用比例网友分享经验:
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Therapeutic Advances in Medical Oncology顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
编辑信息 Managing Editor
Georgia Patey
SAGE Publications Ltd, UK

Associate Editors
Rodabe AmariaDepartment of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Aditya BardiaMassachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA

Ian DavisEastern Health Clinical School, Monash University, Australia

Karim FizaziInstitut Gustave Roussy, University of Paris Saclay, France

Sharlene GillMedical Oncology, BC Cancer - Vancouver, University of British Columbia, Canada

Robert HaddadDivision of Head and Neck Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA

Pascal HammelBeaujon Hospital, Clichy, France

Nadia HarbeckUniversity of Munich, Germany

Sara HurvitzDavid Geffen School of Medicine and Jonsson Comprehensive Cancer Center, UCLA, CA, USA

Jonathan LedermannUCL Cancer Institute, University College London, UK

Natasha LeighlDepartment of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada

Karl LewisUniversity of Colorado School of Medicine, CO, USA

Javier Martin-BrotoFundacion Jimenez Diaz University Hospital, Madrid, Spain

Ana OakninVall d’Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron, Barcelona, Spain

Keunchil ParkDepartment of Thoracic/Head and Neck Medical Oncology, University of Texas M.D. Anderson Cancer Center, TX, USA

Matthias PreusserDivision of Oncology, Department of Medicine I, Medical University of Vienna, Austria

Liang QiaoThe University of Sydney, Westmead, Australia

Rachel RiechelmannClinical Oncology Department, AC Camargo Cancer Center, Sao Paulo, Brazil

Ross SooDepartment of Haematology-Oncology, National University Cancer Institute, Singapore

Srikala SridharPrincess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada

David TanUniversity of Washington, USA

Hanneke van LaarhovenDepartment of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, the Netherlands

Arndt VogelMedical School Hannover, Hannover, Germany
期刊常用信息链接
同领域相关期刊 Therapeutic Advances in Medical Oncology期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Therapeutic Advances in Medical Oncology中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Therapeutic Advances in Medical Oncology上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE599868
    BIOMATERIALS512726
    BIOMEDICINE & PHARMACOTHERAPY461888
    Journal of Materials Chemistry B458423
    Frontiers in Pharmacology448238
    Frontiers in Immunology419238
    JOURNAL OF ETHNOPHARMACOLOGY403621
    COLLOIDS AND SURFACES B-BIOINTERFACES403102
    Frontiers in Oncology382542
    Acta Biomaterialia374652
  •  

    Therapeutic Advances in Medical Oncology Therapeutic Advances in Medical Oncology
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Survival benefit of thoracic radiotherapy plus EGFR-TKIs in patients with non-oligometastatic advanced non-small-cell lung cancer: a single-center retrospective study

    Author: Zhou, Fangyuan; Qin, You; Liu, Xixi; Huang, Jing; Wu, Bian; Zhang, Zhanjie; Yin, Zhongyuan; Yang, Jinsong; Zhang, Sheng; Jiang, Ke; Yang, Kunyu
    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2023; Vol. 15, Issue , pp. -. DOI: 10.1177/17588359231161411
        PubMed      DOI
    2.Correlation of preclinical and clinical biomarkers with efficacy and toxicity of cancer immunotherapy

    Author: Zheng, Lin-Peng; Yang, Jing; Chen, Xie-Wan; Li, Ling-Chen; Sun, Jian-Guo
    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2023; Vol. 15, Issue , pp. -. DOI: 10.1177/17588359231163807
        PubMed      DOI
    3.Rationale and value of consolidative cranial local therapy in EGFR-mutant non-small cell lung cancer patients with baseline brain metastasis treated with first-line EGFR-TKIs

    Author: Zeng, Ya; Su, Xi; Zhao, Yang; Zhou, Yue; Guo, Tiantian; Chu, Xiao; Chu, Li; Yang, Xi; Ni, Jianjiao; Zhu, Zhengfei
    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2023; Vol. 15, Issue , pp. -. DOI: 10.1177/17588359231169975
        PubMed      DOI
    4.Development and validation of prognostic nomograms for large hepatocellular carcinoma after HAIC

    Author: Yao, Wang; Wei, Ran; Jia, Jia; Li, Wang; Zuo, Mengxuan; Zhuo, Shuqing; Shi, Ge; Wu, Peihong; An, Chao
    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2023; Vol. 15, Issue , pp. -. DOI: 10.1177/17588359231163845
        PubMed      DOI
    5.Treatment strategies based on different oligoprogressive patterns after immunotherapy failure in metastatic NSCLC

    Author: Xuzhang, Wendi; Huang, Huayan; Yu, Yongfeng; Shen, Lan; Li, Ziming; Lu, Shun
    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2023; Vol. 15, Issue , pp. -. DOI: 10.1177/17588359231156387
        PubMed      DOI
    6.Molecular landscape and emerging therapeutic strategies in breast cancer brain metastasis

    Author: Xiong, Siyi; Tan, Xuanni; Wu, Xiujuan; Wan, Andi; Zhang, Guozhi; Wang, Cheng; Liang, Yan; Zhang, Yi
    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2023; Vol. 15, Issue , pp. -. DOI: 10.1177/17588359231165976
        PubMed      DOI
    7.Circulating tumor cells dynamics during chemotherapy predict survival and response in advanced non-small-cell lung cancer patients

    Author: Wang, Zhen; Zhang, Xu-Chao; Feng, Wei-Neng; Zhang, Li; Liu, Xiao-Qing; Guo, Wei-Bang; Deng, Yan-Ming; Zou, Qing-Feng; Yang, Jin-Ji; Zhou, Qing; Wang, Bin-Chao; Chen, Hua-Jun; Tu, Hai-Yan; Yan, Hong-Hong; Wu, Yi-Long
    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2023; Vol. 15, Issue , pp. -. DOI: 10.1177/17588359231167818
        PubMed      DOI
    8.The association between HER2-low expression and prognosis of breast cancer: a systematic review and meta-analysis

    Author: Tang, Yuyao; Shen, Guoshuang; Xin, Yuanfang; Li, Zhoujuan; Zheng, Yonghui; Wang, Miaozhou; Liu, Zhen; Zhao, Yi; Zhao, Fuxing; Ren, Dengfeng; Zhao, Jiuda
    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2023; Vol. 15, Issue , pp. -. DOI: 10.1177/17588359231156669
        PubMed      DOI
    9.A phase Ia dose-escalation trial of Ametumumab (a fully human monoclonal antibody against epidermal growth factor receptor) in patients with advanced solid malignancies

    Author: Li, Da; Pan, Hong; Wang, Wei; Xue, Yanan; Fang, Yong; Lou, Haizhou; Pan, Qin; Jin, Wei; Zheng, Yu; Han, Weidong; Zhu, Kongli; Zhao, Xianfeng; Xu, Rong; Han, Jin; Pan, Hongming
    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2023; Vol. 15, Issue , pp. -. DOI: 10.1177/17588359231165968
        PubMed      DOI
    10.Clinical utility of pretreatment serum squamous cell carcinoma antigen for prognostication and decision-making in patients with early-stage cervical cancer

    Author: Huang, Xiao-Dan; Huo, Lan-Qing; Luo, Ying-Shan; Chen, Kai; Li, Jun-Yun; Shi, Liu; Huang, Lin; Cao, Xin-Ping; Ou-Yang, Yi; Chen, Fo-Ping
    Journal: THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2023; Vol. 15, Issue , pp. -. DOI: 10.1177/17588359231165974
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    Living Reviews in Relativity065.50
    Living Reviews in Relativity7565.50
    JOURNAL OF TRAVEL MEDICINE5119.60
    Military Medical Research030.10
    Advanced Composites and Hybrid Materials016.90
    INTERNATIONAL JOURNAL OF COMPUTER VISION17222.50
    Eurosurveillance9027.70
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE715.70
    Small Structures00.00
    Trends in Chemistry032.10


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共96条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451